% | $
Quotes you view appear here for quick access.

Lpath Inc. Message Board

  • thebigfella1234 thebigfella1234 May 7, 2013 4:45 PM Flag

    10 Q

    from the 10Q

    "As part of the Pfizer Agreement, Lpath has granted to Pfizer a time-limited right of first refusal for ASONEP which period ends when the iSONEP Nexus clinical trial is completed." i may have forgotten, but i thought there was a hard and fast date on the option. didnt realize that it was flexible. so this puts off any other prospective partners through mid 2014 (nexus completion) i still say the option on asonep is a buy out strategy by pfizer.

    geez, as i type that, it sounds sooooo far off.

    also, didnt like this much " The target date to begin testing Lpathomab in clinical trials is in early 2015" no mention of dod. this is gonnal be a long slow grind

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.68-0.50(-15.72%)Aug 23 4:00 PMEDT